Clinical Trial

Advanced or Recurrent Solid Tumors Treated With SHetA2

Name: Advanced or Recurrent Solid Tumors Treated With SHetA2 — clinical trial record (NCT04928508)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Okgyn1

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this research is to test the safety of the study drug (OK-1) and see what effects (good and bad) this drug has on patients with recurrent solid tumors.

Protocol Amendment History 1 change

notable Primary completion pushed: 2026-05 -> 2026-09 2026-07-31

Trial Details

NCT Number	NCT04928508
Lead Sponsor	University of Oklahoma Collaborators: National Cancer Institute (NCI)
Conditions	Solid Tumor, Adult
Enrollment	50 participants
Start Date	2022-07-27
Primary Completion	2026-09 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-30